Evaluation of Sexual Dysfunctions in Substance Use Disorder

Area of Science:

• Psychiatry
• Urology
• Addiction Medicine

Background:

• Substance use disorder (SUD) is frequently associated with various health complications, including sexual dysfunction (SD).
• Understanding the prevalence and correlates of SD in SUD patients is crucial for comprehensive treatment.

Purpose of the Study:

• To determine the prevalence of sexual dysfunction (SD) in patients diagnosed with substance use disorder (SUD).
• To examine the association between SD and sociodemographic/clinical characteristics in SUD patients.

Main Methods:

• 176 SUD patients (157 males, 19 females) aged 18-45 were assessed.
• Standardized questionnaires including HADS, IIEF, PEDT, ASEX-M (males), FSFI, and ASEX-F (females) were used.
• Patients were categorized into single SUD, multiple SUD, and buprenorphine-naloxone (BPN) treatment groups.

Main Results:

• Prevalence of erectile dysfunction (ED) was 49.7% and premature ejaculation (PE) was 48.4% in males.
• No significant differences in ED or PE prevalence were found between SUD groups.
• Depression and anxiety symptoms negatively correlated with multiple aspects of sexual function in males.

Conclusions:

• Sexual dysfunction outcomes were similar across single SUD, multiple SUD, and BPN treatment groups.
• Co-occurring depressive and anxiety symptoms significantly impact sexual functioning in SUD patients.
• A multidimensional approach is needed for assessing and managing sexual health in SUD.